Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

Our Products
Overview
Partnering Search
Company Profiling
Partneringtools
Reports
Partnering Consulting
Comparison
 
Forums
Visit our forums
 
Jobs
Visit our job site
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire New!
 
Contact us
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing Ltd
is a division of
UTEK Corporation
In-licensing

Licensing Opportunities in Ophthalmology drugs or therapeutic devices

Goldshield
Ophthalmology drugs or therapeutic devices

Full description

Opportunities in Ophthalmology drugs or therapeutic devices in Dry Eyes  Eye Infections Ocular Inflammation Glaucoma Macular Degeneration and Vitreo-retinal conditions Conjunctivitis with a well defined edge over current therapy

 

 

 

Development status

Phase III

Type of business relationship sought

Please get in touch with

Nivedita Valentine, Strategic Business Development

Tel : +44 (0)2085889114 ,E Mail : n.valentine@goldshieldplc.com 

Licensing contact

Business Development
Licensing
Request more information

Company details

Goldshield
Goldshield is a global Pharmaceutical and Healthcare company headquartered in the UK, seeking new product opportunities in the following areas: Cardiology, Ophthalmology, Dermatology, Urology

Related reports

Are you looking for reports related to this particular subject. Our Reports section is the best place to start.

Related items

Related categories

Industry sector
Drug delivery
Pharmaceutical
Therapeutic target
Sensory organ
Partnering consultation free of charge
Need competitive intelligence information
Industry news: Pharmalicensing provides comprehensive industry coverage.

© Copyright 1995-2008 Pharmalicensing Ltd, is a division of UTEK Corporation All rights reserved. Terms and Conditions | Site map | Contact us